 |
News
- Abbott Hosts Conference Call for Second-Quarter Earnings
- Abbott Receives CE Mark for Company's Next-Generation XIENCE PRIME™ Drug Eluting Stent, Advancing Leadership Position
- Abbott Initiates Trial of Next-Generation XIENCE PRIME™ Drug Eluting Stent, Building Upon Superior Outcomes from SPIRIT Family of Trials
Features
|
Abbott's Bioabsorbable Stent Featured in Popular Science A recent Popular Science article highlights the innovation of Abbott's fully bioabsorbable coronary device. |
|
Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore Our new state-of-the-art nutrition manufacturing facility has officially opened in Singapore, representing Abbott’s growing commitment to the region and our single largest investment in Asia. |
|
Abbott's Commitment to Child Nutrition For more than 100 years, Abbott has been a leader in developing innovative, science-based nutrition solutions that help children develop and grow, and live healthier lives. Learn more about the information and support available to ensure children receive the optimal form of nutrition. |
|
Abbott's Commitment in HIV/AIDS Learn how Abbott is fighting this disease around the world by expanding access to treatment, supporting children affected by the virus, and strengthening health care systems. |
